Cargando…

Increased p16 and p53 protein expression predicts poor prognosis in mucosal melanoma

Primary mucosal melanoma (MM) is a rare, and aggressive, neoplasm with a poor prognosis. To date, few prognostic markers of MM have been well-defined. The aim of this study is to clarify the prognostic value of p53 and p16 proteins in predicting the clinical outcome of Chinese patients with MM. A to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Hanbin, Li, Yangyang, Long, Yin, Tang, Erjiang, Wang, Rongrong, Huang, Kate, Xie, Congying, Chen, Guorong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581105/ https://www.ncbi.nlm.nih.gov/pubmed/28881806 http://dx.doi.org/10.18632/oncotarget.18367

Ejemplares similares

p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis
por: Matin, Rubeta N., et al.
Publicado: (2013)

The Tumor Suppressor p53 in Mucosal Melanoma of the Head and Neck
por: Fritsche, Marie Kristin, et al.
Publicado: (2017)

Cytoplasmic p53 aggregates accumulated in p53-mutated cancer correlate with poor prognosis
por: Iwahashi, Naoyuki, et al.
Publicado: (2022)

Overexpression of p53R2 is associated with poor prognosis in lung sarcomatoid carcinoma
por: Chen, Jiewei, et al.
Publicado: (2017)

Antibodies against p53 are associated with poor prognosis of colorectal cancer.
por: Houbiers, J. G., et al.
Publicado: (1995)

p53 protein expression in nephroblastomas: a predictor of poor prognosis.
por: Govender, D., et al.
Publicado: (1998)

p53 mutation, deprivation and poor prognosis in primary breast cancer
por: Baker, L, et al.
Publicado: (2010)

Nuclear p53 Immunoreaction Associated with Poor Prognosis of Breast Cancer
por: Iwaya, Keiichi, et al.
Publicado: (1991)

p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer.
por: Linn, S. C., et al.
Publicado: (1996)

CDK16 Phosphorylates and Degrades p53 to Promote Radioresistance and Predicts Prognosis in Lung Cancer
por: Xie, Jie, et al.
Publicado: (2018)

Long-noncoding RNA MALAT1 sponges microRNA-92a-3p to inhibit doxorubicin-induced cardiac senescence by targeting ATG4a
por: Xia, Wenzheng, et al.
Publicado: (2020)

Evaluation of p53 gene expression and prognosis characteristics in uveal melanoma cases
por: Liu, Haojie, et al.
Publicado: (2017)

Loss of nuclear BAP1 expression is associated with poor prognosis in oral mucosal melanoma
por: Song, Hao, et al.
Publicado: (2017)

miR-138-5p induces aggressive traits by targeting Trp53 expression in murine melanoma cells, and correlates with poor prognosis of melanoma patients
por: da Cruz, Adriana Taveira, et al.
Publicado: (2021)

Metabolic Pathways Enhancement Confers Poor Prognosis in p53 Exon Mutant Hepatocellular Carcinoma
por: Chen, Po-Ming, et al.
Publicado: (2020)

Elevated p53 expression levels correlate with tumor progression and poor prognosis in patients exhibiting esophageal squamous cell carcinoma
por: HUANG, KATE, et al.
Publicado: (2014)

Mutant p53 and Twist1 Co-Expression Predicts Poor Prognosis and Is an Independent Prognostic Factor in Breast Cancer
por: Zhang, Yong-Qu, et al.
Publicado: (2021)

Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinoma
por: Ernoux-Neufcoeur, Perle, et al.
Publicado: (2010)

Diagnostic p53 expression in gastric endoscopic mucosal resection.
por: Cho, J. H., et al.
Publicado: (1999)

Increased serum p53 antibody levels indicate poor prognosis in patients with colorectal cancer.
por: Kressner, U., et al.
Publicado: (1998)

Serum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade
por: Wu, C-W, et al.
Publicado: (1999)

Polymorphism of p53 in cancer prognosis
por: Pillai, Radhakrishna Madhavan, et al.
Publicado: (2016)

PD-1 inhibitor inducing exosomal miR-34a-5p expression mediates the cross talk between cardiomyocyte and macrophage in immune checkpoint inhibitor–related cardiac dysfunction
por: Xia, Wenzheng, et al.
Publicado: (2020)

Dominant effects of Δ40p53 on p53 function and melanoma cell fate
por: Takahashi, Rie, et al.
Publicado: (2013)

WT1, p53 and p16 expression in the diagnosis of low- and high-grade serous ovarian carcinomas and their relation to prognosis
por: Sallum, Luis Felipe, et al.
Publicado: (2018)

Immunostaining for p53 and p16(CDKN2A) Protein Is Not Predictive of Prognosis for Dogs with Malignant Mammary Gland Neoplasms
por: Munday, John S, et al.
Publicado: (2019)

High Expression of MDM2 and the p53 Protein is Predictive Biomarkers for Poor Prognosis of Oesophageal Squamous Cell Carcinoma
por: Ye, Juan, et al.
Publicado: (2021)

p16 protein expression is associated with a poor prognosis in squamous cell carcinoma of the lung
por: Huang, C-I, et al.
Publicado: (2000)

pTERT C250T mutation: A potential biomarker of poor prognosis in metastatic melanoma
por: Blanco-García, Leyla, et al.
Publicado: (2023)

p16, pRb, and p53 in Feline Oral Squamous Cell Carcinoma
por: Supsavhad, Wachiraphan, et al.
Publicado: (2016)

Circulating Neutrophils Predict Poor Survival for HCC and Promote HCC Progression Through p53 and STAT3 Signaling Pathway
por: Wang, Yan, et al.
Publicado: (2020)

p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosis.
por: Jaros, E., et al.
Publicado: (1993)

High α B-crystallin and p53 co-expression is associated with poor prognosis in ovarian cancer
por: Tan, Lin, et al.
Publicado: (2019)

Association of p53 expression with poor prognosis in patients with triple-negative breast invasive ductal carcinoma
por: Li, Jing-ping, et al.
Publicado: (2019)

miR-18a expression correlates with ATM and p53 levels and poor prognosis in lymphomas
por: Zhou, Hao, et al.
Publicado: (2023)

Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb
por: Hitchings, A W, et al.
Publicado: (2004)

Increased expression and mutation of p53 in choroidal melanoma.
por: Tobal, K., et al.
Publicado: (1992)

p53 Regulation by TRP2 Is Not Pervasive in Melanoma
por: Houben, Roland, et al.
Publicado: (2014)

p53 Family in Resistance to Targeted Therapy of Melanoma
por: Vlašić, Ignacija, et al.
Publicado: (2022)

Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up.
por: Thompson, A. M., et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_vpi6fc76a5h6g8rchcpnttugth